Nuclear medicine imaging to predict response to radiotherapy: a review
- 1 January 2003
- journal article
- review article
- Published by Elsevier in International Journal of Radiation Oncology*Biology*Physics
- Vol. 55 (1) , 5-15
- https://doi.org/10.1016/s0360-3016(02)04122-6
Abstract
No abstract availableKeywords
This publication has 63 references indexed in Scilit:
- 99Tcm labelled HL91 versus computed tomography and biopsy for the visualization of tumour recurrence of squamous head and neck carcinomaNuclear Medicine Communications, 2001
- Metabolic studies of [18F-?? -methyl]tyrosine in mice bearing colorectal carcinoma LS-180Anti-Cancer Drugs, 1999
- The in Vivo Metabolic Pattern of Low-grade Brain Gliomas: A Positron Emission Tomographic Study Using 18F-fluorodeoxyglucose and11 C-L-methylmethionineNeurosurgery, 1997
- Early Prediction of Treatment Outcome in Head and Neck Cancer with 2-18FDG PETActa Oncologica, 1997
- Apoptosis and downstaging after preoperative radiotherapy for muscle-invasive bladder cancerInternational Journal of Radiation Oncology*Biology*Physics, 1996
- Review: How Amino Acids Get Into Cells: Mechanisms, Models, Menus, and MediatorsJournal of Parenteral and Enteral Nutrition, 1992
- Suitability of rodent tumor models for experimental PET with l-[1-11C]tyrosine and 2-[18F]fluoro-2-deoxy-d-glucoseInternational Journal of Radiation Applications and Instrumentation. Part B. Nuclear Medicine and Biology, 1991
- Production of [2-11C]thymidine for quantification of cellular proliferation with PETInternational Journal of Radiation Applications and Instrumentation. Part A. Applied Radiation and Isotopes, 1991
- Differential Diagnosis of AH109A Tumor and Inflammation by Radioscintigrap with l‐[Methyl‐11C]methionineJapanese Journal of Cancer Research, 1989
- Scintigraphy with positron-emitting compounds—I. Carbon-11 labeled thymidine and thymidylateInternational Journal of Nuclear Medicine and Biology, 1978